Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 5, 2026BiomedicinesOpen Access

Novel TBX20 Variations Susceptible to Sporadic Atrial Fibrillation

View Full Paper
Ask AI
Bookmark
Share

Why the study?

TBX20 mutations contribute to familial AF, but the mutational prevalence and spectrum of this gene in sporadic AF remain unknown.

Are TBX20 variations associated with susceptibility to sporadic atrial fibrillation?

Population

352 individuals with sporadic AF and 376 healthy subjects without AF history

Comparison

Individuals with sporadic AF vs healthy subjects without AF history

Design

Prospective case-control genetic association and functional study

Key result

Two novel heterozygous truncating TBX20 variations were detected in 0.57% of patients with sporadic atrial fibrillation, but were absent in healthy controls.

Authors

ZXZhen-Yu XuDZDao-Liang ZhangXQXing‐Biao Qiu

Discussion

Loading...

Member takes

Overview

Rare TBX20 truncating variants may predispose to sporadic AF; extends genetic spectrum but leaves open clinical relevance pending replication.

Key Points

  • To investigate the prevalence, spectrum, and functional consequences of TBX20 gene variations in patients with sporadic atrial fibrillation.
  • Prospectively recruited 352 individuals with sporadic atrial fibrillation and 376 healthy controls without a history of atrial fibrillation.
  • Performed Sanger sequencing of the TBX20 gene in all 728 participants.
  • Assessed the functional impact of identified variants on target promoters (KCNH2, NPPA) and synergistic activation with NKX2.5 using dual-reporter gene assays.
  • Identified two novel heterozygous truncating TBX20 variants, p.(Ser242*) and p.(Lys276*), in 2 of 352 sporadic AF cases (prevalence of ~0.57%), while neither variant was found across 752 control chromosomes.
  • Functional assays demonstrated that both Ser242* and Lys276* variants completely lost transactivation capacity on KCNH2 and NPPA promoters.
  • Both variants abolished the synergistic transactivation of the NPPA promoter normally mediated by TBX20 in combination with NKX2.5.

Study Design

Type

Case-Control (n=728)

Structured PICO

Are TBX20 variations associated with susceptibility to sporadic atrial fibrillation?

P
Population
728 individuals, comprising 352 with sporadic atrial fibrillation and 376 healthy controls, prospectively recruited for genetic analysis.
E
Exposure
Sanger sequencing of TBX20 and functional measurement by dual-reporter gene analysis
C
Comparator
376 healthy subjects without AF history
O
Outcome
Detection of TBX20 variations and their functional impacts on transactivation of KCNH2 and NPPAsurrogate

Main Result

Absolute Event Rate: 0.57% vs 0%

Novel haplo-insufficient TBX20 variations are identified as genetic defects predisposing to sporadic atrial fibrillation, expanding the genetic spectrum of the disease.

Cite This Study

Xu et al. (2026) conducted a case-control in Sporadic Atrial Fibrillation (n=728). TBX20 variations vs. Healthy subjects without AF history was evaluated on Presence of TBX20 variations. Two novel heterozygous truncating TBX20 variations were detected in 0.57% of patients with sporadic atrial fibrillation, but were absent in healthy controls.

synapsesocial.com/papers/6a9bd4606b95aff0620ec090https://doi.org/10.3390/biomedicines14091990
View Full Paper
Ask AI
Bookmark
Share